Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Michael Richard Verneris

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Verneris, Michael

One or more keywords matched the following items that are connected to Verneris, Michael

Item Type	Name
Concept	Immunotherapy
Concept	Immunotherapy, Adoptive
Academic Article	The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.
Academic Article	The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.
Academic Article	Use of natural killer cells as immunotherapy for leukaemia.
Academic Article	One-unit versus two-unit cord-blood transplantation for hematologic cancers.
Academic Article	Recent developments in cell-based immune therapy for neuroblastoma.
Academic Article	Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition.
Academic Article	Clinical utility of natural killer cells in cancer therapy and transplantation.
Academic Article	Immunotherapy for pediatric cancer.
Academic Article	Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
Academic Article	Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.
Academic Article	Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.
Academic Article	Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in?vivo cytokine administration: implications for clinical therapy.
Academic Article	Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer.
Academic Article	Killing the killer: natural killer cells to treat Ewing's sarcoma.
Academic Article	Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
Academic Article	Acquisition, preparation, and functional assessment of human NK cells for adoptive immunotherapy.
Academic Article	Visualization of tumor growth and response to NK-T cell based immunotherapy using bioluminescence.
Academic Article	Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD.
Academic Article	Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma.
Academic Article	Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.
Grant	ACTIVITY OF EXPANDED GAMMA/DELTA T CELLS
Academic Article	Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia.
Academic Article	Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia.
Academic Article	Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.
Academic Article	Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.
Academic Article	Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.
Academic Article	Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
Academic Article	Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Academic Article	Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.
Academic Article	Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.

Search Criteria

Immunotherapy